ANI Pharmaceuticals, Inc. (ANIP) Stock Overview
Explore ANI Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
ANI Pharmaceuticals, Inc. (ANIP)
Key Financials
Key Financials
Market Cap
1.7B
P/E Ratio
15.49
EPS (TTM)
$8.22
ROE
0.19%
ANIP Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of A, ANI Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ANIP on the NASDAQ shows an RSI of 38.60, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $90.86 for the NASDAQ listing.
Key metrics behind ANI Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of 15.49 and a market capitalization of 1.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ANIP on the NASDAQ.